Daily assessment of arterial distensibility in a pediatric population before and after smoking cessation by Bassareo, Pier Paolo et al.
Daily assessment of arterial distensibility in a
pediatric population before and after smoking
cessation
Pier Paolo Bassareo,I Vassilios Fanos,II Antonio Crisafulli,III Giuseppe MercuroI
IUniversity of Cagliari, Department of Medical Sciences ‘‘M. Aresu’’, Unit of Cardiology and Angiology, Cagliari, Italy. IIUniversity of Cagliari, Department
of Surgery, Section of Neonatal Intensive Care Unit and Puericulture, Cagliari, Italy. IIIUniversity of Cagliari, Department of Medical Sciences ‘‘M. Aresu’’,
Sport Physiology Laboratory, Cagliari, Italy.
OBJECTIVES: Cigarette smoking is an important modifiable cardiovascular risk factor associated with increased
stiffness of the large arteries in adulthood. This study aimed to 1) evaluate arterial distensibility and
echocardiographic measures in adolescent smokers before and after participation in a successful smoking
cessation program and to 2) compare the findings obtained with data from a control population of healthy
non-smokers.
METHODS: A total of 31 young smoking subjects (58.1% male; range: 11-18 years old; mean: 16.5¡1.4 years
old; mean tobacco consumption: 2.6¡0.6 years) were examined before commencing and after taking part for
at least 1 year in a smoking cessation program (mean: 1.4¡0.3 years). Arterial stiffness was measured using the
previously validated QKd100-60 method. Twenty-four-hour ambulatory blood pressure monitoring and
transthoracic echocardiography were also performed.
RESULTS: (Smokers before abuse cessation vs. smokers after abuse cessation) systolic blood pressure: p,0.004;
diastolic blood pressure: p,0.02; mean blood pressure: p,0.01; QKd100-60 value: 183¡5 vs. 196¡3 msec,
p,0.009; p=ns for all echocardiographic parameters. (Smokers after abuse cessation vs. controls) systolic blood
pressure: p,0.01; diastolic blood pressure: p,0.03; mean blood pressure: p,0.02; QKd100-60 value: 196¡3 vs.
203¡2 msec, p,0.04; p,0.02, p,0.01, and p,0.05 for the interventricular septum, posterior wall, and left
ventricular mass, respectively.
CONCLUSIONS: Despite successful participation in a smoking cessation program, arterial distensibility improved
but did not normalize. This finding underlines the presence of the harmful effect of arterial rigidity in these
individuals, despite their having quit smoking and their young ages, thus resulting in the subsequent need for a
lengthy follow-up period.
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& INTRODUCTION
Cigarette smoking is a major preventable cause of car-
diovascular disease. It has been estimated to underpin up to
30% of all deaths from coronary heart disease, with a strong
dose-related risk. Moreover, smoking significantly increases
the risk of ischemic stroke, peripheral vascular disease,
cancer, chronic lung disease, and numerous other chronic
diseases (1,2).
Generally speaking, while the adverse effects of smoking
become manifest in the fourth to fifth decades of life, the
majority of smokers (SMs) acquire the habit in their early or
mid-teens (3).
SMs are at an increased risk of developing accelerated
atherosclerosis, as indicated by previous findings of struc-
tural anomalies in the carotid and brachial arteries of adult
chronic SMs (4-6).
Increased vascular oxidative stress has also been detected
in the arteries of passive SMs, as revealed by impaired flow-
mediated vasodilatation, an early marker of atherosclerosis
(7). Furthermore, loss of the natural elasticity of the aorta
could likewise be responsible for the higher blood pressure
values registered in SMs (8). However, significant improve-
ment in arterial distensibility has been demonstrated in a
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number of studies of adult former SMs after smoking
cessation programs lasting from 6 months to 2 years (9-16).
However, all of the reports published to date on tobacco-
induced diseases and the effects of smoking cessation have
focused on adult patients. It therefore remains to be clarified
whether these findings can be translated to adolescent SMs,
who have a shorter history of tobacco use compared with
adults.
The QKd interval is the time (measured in milliseconds)
between the onset of depolarization on electrocardiography
(Q) and detection of the last Korotkoff sound (K) at
the brachial artery during cuff deflation, corresponding to
the diastolic blood pressure (d). The clinical validation,
reproducibility, and prognostic value of the QKd index in
providing valuable information on arterial compliance have
been established by several previously published studies
conducted on subjects with either normal or high blood
pressure. Before the age of 30 years old, the QKd index is
related to height but not age (17-23). The QKd technique has
previously been validated in comparison to pulse wave
velocity (19). Previous studies in pediatric patients have
been performed as well (24,25). Because this interval
is inversely correlated with pulse wave velocity, QKd
measurement provides valuable information on arterial
distensibility, as it is calculated using an arterial segment
including the ascending aorta and a portion of the sub-
clavian and brachial arteries (20).
The present study aimed to 1) evaluate arterial compli-
ance before and after smoking cessation in adolescent SMs,
2) compare data obtained after smoking cessation with those
from a control group (C) of healthy non-SMs, and 3)
evaluate the echocardiographic data of adolescent SMs
before and after quitting smoking.
This study is believed to be the first to investigate the
effects of smoking cessation on arterial stiffness in a cohort
of adolescent subjects. Based on the findings of previous
studies performed in adults to investigate the reduction
(but not normalization) in vascular damage induced by
smoking cessation, the authors investigated the possibility
for adolescents to achieve goals that were not achieved in
adults.
& PATIENTS AND METHODS
Selection of study participants
Thirty-eight participants were initially enrolled, although
only 31 were included in the statistical analysis due to the
exclusion of seven young subjects who proved unable to
quit smoking.
Accordingly, thirty-one pediatric subjects (18 males and
13 females) with the habit of smoking up to 1 pack-year
(from 8 to 20 cigarettes/day) and aged between 11 and
18 years old (mean age: 16.5¡1.4 years) were included in
the study. The mean duration of tobacco use was 2.6¡0.6
years. All of the subjects were examined at the time of
enrollment (confirmation of at least 48 hours of abstinence
from smoking was ascertained by dosing nicotine metabo-
lites in the urine) and, subsequently, after having quit
smoking for at least 1 year (mean: 1.4¡0.3 years). At the
time of the second evaluation, abstinence from smoking was
likewise ascertained by assessing the presence of nicotine
metabolites in the urine. Furthermore, during the 1-year
smoking cessation program, three additional urine controls
were performed to confirm smoking cessation. Specifically,
urinary levels of the nicotine metabolite cotinine were
assessed (26). Cotinine levels ,10 ng/mL were considered
consistent with no active smoking.
At baseline and follow-up, all SMs were strictly followed
for 24 hours by their parents to ascertain their abstinence
from both caffeine-containing beverages and physical
exercise, both of which are potentially capable of affecting
the evaluation of arterial stiffness. No cases of alcohol intake
or drug abuse or addiction were reported between the
baseline and follow-up examinations.
The young participants in the study quit smoking with
the aid of a psychosocial program (based on peer pressure,
parents as role models, the health consequences of smok-
ing, the cost of smoking, tips for quitting smoking, and
responsible decision making) (27). In Italy, nicotine replace-
ment therapy and varenicline have not been approved for
use in patients younger than 18 years old (28).
SMs were compared with a C of 31 healthy subjects
paired with regard to sex, age, height, and weight. The
controls were healthy subjects visited for certification of
eligibility in sports. The exclusion criteria were the same in
the study population and controls, i.e., conditions that
increase the pre-ejection period and conditions that might
impair interpretation of the QKd interval (such as severe
subvalvular aortic stenosis, hyperthyroidism, presence of a
pacemaker, left bundle branch block, and atrial fibrillation)
(20). Subjects suffering from diseases known to influence
arterial compliance (e.g., diabetes or autoimmune patholo-
gies) were also excluded from the study. In this regard,
three subjects were not enrolled because they were suffering
from diabetes.
Table 1 shows the main clinical characteristics of the 31
smoking subjects and the controls.
Twenty-four-hour ambulatory blood pressure monitoring
(ABPM), QKd interval measurement (at baseline and at the
end of the study), 12-lead surface ECG (at baseline), and
transthoracic echocardiography (at baseline and at the end
of the study) were performed for each study participant. In
the smoking group, none of the enrolled subjects exhibited
arterial hypertension.
This case-control study commenced in January 2001 and
was finished in March 2012, due to the objective difficulty in
recruiting this type of young subject. All of the young
patients’ parents gave their informed written consent for
the study, which was conducted according to the Helsinki
Declaration.
QKd interval measurement
The authors performed 24-hour ABPM using the aus-
cultatory mode, coupled with measurement of the QKd
interval, to evaluate the rigidity of the large arteries. A
microphone was located in the cuff on the brachial artery,
and three electrodes were placed on the subject’s chest to
detect QRS complexes. The QKd interval was measured
together with concomitant cardiac frequency and blood
pressure values every 15 minutes over a 24-hour period
(approximately 96 values for each subject). QKd interval
variations were automatically detected by a monitoring
device, using purpose-developed software (Dyasis Integra
from Novacor, Rueil Malmaison, France). This index
provides an estimate of arterial distensibility derived from
the pulse wave velocity (29). The measurement of the latter
is undoubtedly the oldest method available for use in
estimating the rigidity of an arterial segment. The principle
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of this technique is fairly simple: the more rigid the artery is,
the more quickly the vibration generated by the ventricular
ejection transmitted by the arterial wall is. With regard to
the previously reported strong inverse relationship between
pulse wave velocity and the QKd index, any elevation of the
former results in a shortening of pulse wave transmission
time and, therefore, of the QKd interval. The QKd technique
is therefore closely correlated with the measurement of
pulse wave velocity, and it presents two major advantages:
measurement is completely automatic, and it can be used to
measure different blood pressure levels. It is the variations
in this time according to blood pressure that render the
technique valuable (30).
Application of the above device allowed us to calculate
automatically the QKd 100–60 index, i.e., the value of QKd for
a systolic blood pressure of 100 mmHg and a heart rate of 60
beats per minute, which was totally independent of blood
pressure levels and heart rate. This in turn reduces the
influence of pre-ejection time (linearly correlated to heart
rate) and simplifies comparisons among subjects with
different blood pressure levels (20). It is indeed an acknowl-
edged fact that SMs are at risk of developing hypertension,
even at young ages (31). Values of QKd 100-60 exceeding
200 msec were considered normal (18).
As movement and physical activity frequently result
in invalid readings when using machines that rely on the
detection of Korotkoff sounds with simultaneous ECG
recording, our device was programmed to obtain addi-
tional readings if a likely erroneous reading was recorded.
We followed the generally accepted rule that an ABPM
recording was not acceptable if less than 85% of readings
were suitable for use in analysis (32). Accordingly, 24-h
ABPM was repeated in six of the 31 cases studied. The
device we used was capable of detecting the supine/
orthostatic position of the subjects. The latter aspect,
together with analysis of heart rate variability, provided
relatively certain confirmation that only ABPM data from
SMs registered under relaxed bodily conditions were
analyzed.
Electrocardiography and echocardiography
All of the study participants underwent 12-lead surface
ECG. A transthoracic echocardiographic study was per-
formed by the same trained physician before the evaluation
of arterial compliance by measuring the QKd interval. Left
ventricular mass was calculated using Devereux’s formula
and was indexed by height to the power of 2.7 (33).
Statistical analysis
The sample was tested for normality using the Shapiro-
Wilk test.
The results obtained for the entire smoking population
(n = 31), expressed as means ¡ standard deviations, were
compared to those of the C (n = 31) using the non-parametric
Mann-Whitney U test. Regarding the QKd index, no differ-
ences between the sexes were observed (34). QKd analysis was
performed based on the reference values obtained in previous
studies conducted on subjects with either normal or high
blood pressure (34).
Relationships between the various parameters were
studied by univariate analysis. Multiple stepwise linear
regression analysis was not performed because of the small
sample size. Values of p,0.05 were set as the minimum
level of statistical significance throughout the study.
For all of the analyses, commercially available computer
software (SPSS version 20.0, SPSS Inc., Chicago, Illinois,
USA) was used.
& RESULTS
The participants were divided into two groups (Table 2):
a) smoking subjects prior to a successful smoking cessation
program lasting at least 1 year and b) smoking subjects
following a successful 1-year smoking cessation program.
The first group displayed significant differences in 24-hour
ABPM and heart rate values when compared with data
obtained after the cessation program. The participants were
further divided into two subgroups (Table 3): a) SMs after
stopping smoking and b) controls. Even after the 1-year
cessation program, young former SMs had higher BP values
and higher heart rates when compared with the C.
The 24-h ABPM values were different in former SMs
when compared with the C. Indeed, the nocturnal declines
in diastolic blood pressure were normal in the majority of
the C (66¡4 mmHg diurnal diastolic blood pressure vs.
58¡3 mmHg nocturnal diastolic blood pressure, p= 0.04)
but were reduced in most former SMs (69¡3 mmHg
diurnal diastolic blood pressure vs. 67¡2 mmHg nocturnal
diastolic blood pressure, p.0.05). In the C, nocturnal
declines in diastolic blood pressure were detected in thirty
individuals (dipper cases), whereas a similar finding was
observed in only two members of the 1-year smoking
cessation group (non-dipper cases; p,0.0001). In contrast,
the nocturnal declines in systolic blood pressure were
normal in both previous SMs and the C (ex-SMs: 120¡
6 mmHg diurnal systolic blood pressure vs. 106¡5 mmHg
Table 1 - Clinical characteristics at baseline.
Chronic smoking subjects (n = 31) Control group (n=31) Statistical significance (p-value)
Age (years) 16.5¡1.4 15.9¡1.6 ns
Male subjects 18 18 ns
Female subjects 13 13 ns
Height (cm) 167.7¡5.8 164.9¡6.4 ns
Weight (kg) 63.6¡3.8 65.2¡3.7 ns
Body mass index (kg/m2) 22.7¡1.1 24.1¡0.9 ns
Systolic BP at rest (mmHg) 132.4¡2.9 115.9¡3.3 0.001
Diastolic BP at rest (mmHg) 80.2¡3.5 74.4¡3.0 0.02
Heart rate at rest 78.3¡7.4 62.6¡3.1 0.001
Clinical characteristics (mean values¡ standard deviations) of the 31 chronic smokers, compared with those of the 31 healthy non-smokers in the control
group.
Abbreviations: BP = blood pressure.
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nocturnal systolic blood pressure, p= 0.0001. C: 108¡
6 mmHg diurnal systolic blood pressure vs. 100¡5 mmHg
nocturnal systolic blood pressure, p = 0.001). The C consisted
of 28 dipper cases for systolic blood pressure, and the
smoking group consisted of 25 (p.0.05).
Regarding the echocardiographic data (Table 4), signifi-
cant inter-group differences were observed in left ventri-
cular mass and septal and posterior wall thicknesses.
With regard to the QKd 100–60 index, the values obtained
before and after quitting smoking significantly differed
(183¡5 vs. 196¡3 msec; p,0.009). Furthermore, a statisti-
cally significant difference was observed in the QKd 100–60
index subsequent to smoking cessation when compared
with the control group (196¡3 vs. 203¡2 msec; p,0.04).
Univariate analysis demonstrated significant relation-
ships between the QKd interval and increased blood
pressure values, interventricular septal wall thicknes, and
left ventricular mass (r = 0.51, p= 0.003; r = 0.47, p = 0.007;
r = 0.49, p= 0.004, respectively). No other significant relation-
ships were found.
& DISCUSSION
To the best of our knowledge, no other studies to date
have been undertaken to evaluate the profiles of arterial
stiffness in individuals who were children or adolescents at
the time of tobacco use. The findings obtained in the present
study confirm previous reports of increased rigidity, even at
a very young age, of the large arteries in adult SMs
following smoking cessation (9-16). Increased arterial stiff-
ness could represent the predisposing cause of the higher
24-hour ABPM values in these subjects.
The majority of the former SMs in this study showed a
lack of physiological nocturnal declines in their diastolic
blood pressure values. This non-dipper pattern appears
related to poorer health outcomes and organ damage (32).
Moreover, in the present study, we showed that arterial
compliance was lower in adolescent SMs than in the C, even
after a smoking cessation program lasting at least one year,
with lower QKd values in these individuals than in the C,
based upon pulse wave velocity measurement. The latter
finding emphasizes early deterioration in the physical
properties of the arteries in young SMs that persist after
quitting smoking. In individuals without overt coronary
artery disease, smoking accelerates arterial aging. This
tobacco-induced damage slows after smoking cessation
(35). Even light smoking (i.e., #15 cigarettes/day with #8
pack-years of smoking history) in young healthy indivi-
duals appears to impair vascular function, affecting the
ability of the vascular bed to respond to increased demands,
such as those manifested during physical exercise (36).
Previously, arterial distensibility in SMs (during active
tobacco use or passive exposure to smoke or after quitting
smoking) has been evaluated using indices capable of
providing an evaluation only at the time of examination;
conversely, the QKd interval technique provides a complete
profile of circadian variations in pulse wave velocity
(9,10,37). A 24-hour evaluation would be more appropriate
than a single measurement in assessing arterial elasticity
(38). The vascular damage induced by the two major
compounds in cigarette smoke (nicotine and carbon mon-
oxide) might be responsible for the increased arterial
rigidity in these individuals. Specifically, nicotine acts
preferentially on the large arteries through sympathetic
stimulation and catecholamine release, thus antagonizing
endothelial nitric oxide action and inducing vasoconstric-
tion (39). Carbon monoxide acts on small arteries by
producing carboxyhemoglobin (oxygen is removed from
hemoglobin and is replaced with carbon monoxide), thus
inducing tissue hypoxia and impairment of cellular meta-
bolism at the endothelium). All of these actions set the stage
for the build-up of atherosclerotic plaques (39).
In agreement with previous studies on hypertensive
patients, a relationship was observed between the decrease
in the QKd interval values and increased blood pressure
values, confirming the well-established importance of blood
pressure in arterial compliance (19,40). With regard to the
cardiac repercussions of the reduction in arterial compli-
ance, we found significant relationships between the QKd
interval and the interventricular septal and posterior wall




(n = 31) Statistical significance (p-value)
SBP 24 hours 128¡4 113¡5 0.004
DBP 24 hours 77¡7 68¡6 0.02
MAP 24 hours 111¡6 98¡5 0.01
Heart rate 65¡3 72¡4 0.05
Data from 24-hour ambulatory blood pressure monitoring (smokers before and after a 1-year smoking cessation program. Mean values ¡ standard
deviations).
Abbreviations: SBP = systolic blood pressure; DBP = diastolic blood pressure; MAP = mean arterial pressure.
Table 3 - Twenty-four-hour ambulatory blood pressure monitoring data (before smoking vs. controls).
Smoking Subjects (baseline)
(n = 31)
Control Group subjects (follow-up)
(n = 31) Statistical significance (p-value)
SBP 24 hours 113¡5 104¡6 0.01
DBP 24 hours 68¡2 62¡3 0.03
MAP 24 hours 98¡3 90¡4 0.02
Heart rate 72¡4 82¡5 0.04
Data from 24-hour ambulatory blood pressure monitoring (ex-smoking subjects vs. the control group. Mean values ¡ standard deviations).
Abbreviations: SBP = systolic blood pressure; DBP = diastolic blood pressure; MAP = mean arterial pressure.
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thicknessesand left ventricular mass, similar to previous
observations reported for essential hypertension (41).
In addition, the echocardiographic findings obtained in
this study (SMs vs. the C) were in accordance with previous
reports related to cardiac structural manifestations of
smoking (increased wall thickness and/or cardiac mass) in
animal models (42).
Resting heart rate analysis revealed a significantly higher
cardiac frequency in SMs compared to the C, in accordance
with previously published data (43). Indeed, it is acknowl-
edged that SMs have an increased sympathetic tone (43).
The unexpected higher heart rate in the C, as shown in
Table 3, was most likely due to the involvement of these
subjects in usual daily activities, likely also including light/
moderate physical activity for a number of subjects, in
contrast to the strict control of the SMs during ABP. SMs
alone were controlled for 24 hours. However, as previously
reported, the QKd 100-60 index is completely independent of
blood pressure levels and heart rate.
The main limitations of this study included the small
number of participants and the consequent problems
encountered in implementing the study. These limitations
might have been complicated further by the difficulty in
recruiting this type of young subject (it took several years to
complete the study). Moreover, a smoking cessation
program lasting at least one year might be an insufficient
period over which to evaluate the efficacy of smoking
cessation. A carefully monitored lengthy follow-up study
should be implemented, as previously reported in adult-
hood (likely from 2 to 10 years) (9,44). In this regard, a
continuation of QKd monitoring over a longer period to
investigate potential correlations with arterial calcium
storage, which develops over time, could prove to be of
particular interest.
Additionally, compliance in young subjects is particularly
difficult, with several subjects resuming cigarette smoking
(45). To overcome this issue partially, during the 1-year
quitting smoking program, nicotine metabolites in the
urine were assessed three times to verify abstinence from
smoking. Furthermore, at the end of the smoking cessation
program, a further urine control was performed. Although
the behavioral or medical treatment to be prescribed for
pediatric SMs remains far from consensus, the authors
suggest that all available strategies be used to encourage
and implement smoking cessation programs in these
individuals. By so doing, the specific aim would focus on
increasing long-term smoking cessation rates, preserving
natural aortic elasticity as long as possible, and reducing
the morbidity and mortality associated with cardiovascular
disease (31,46). As an additional limitation, due to the
objective difficulty in recruiting this type of subject, the
study participants were representative of a rather hetero-
geneous group (with a wide age range and a smoking
history that differed in years of regular smoking and
cigarettes smoked per day). This difference might have
resulted in a discrepancy in the degree of arterial distensi-
bility among these individuals, thus potentially explaining
the lack of significant differences in echocardiographic
measurements obtained in SMs at baseline and follow-up.
Finally, other factors potentially contributing to the reduc-
tion in arterial compliance in SMs should be considered
(e.g., elevated levels of plasma renin, catecholamines, and
other endogenous vasoactive compounds and a family
history of hypertension) (44).
In conclusion, the data obtained in this study demon-
strated that SMs displayed early increased arterial stiffness
(demonstrated by the changes captured using the QKd test)
even in adolescence, regardless of the completion of a
tobacco-use cessation program.
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